Maija Itälä-Remes profile picture
Maija
Itälä-Remes
Professor, Internal Medicine
MD, PhD, Adjunct professor

Contact

Links

Curriculum.pdf
Publications Full.pdf

Areas of expertise

Haematology
Acute Leukemia
Haematopoietic Stem Cell Transplantation

Biography

Academic degrees:

Medical doctor 26.5.1986, University of Turku, Finland
Doctoral thesis (”B-cell Chronic Lymphocytic Leukemia and Increased Susceptibility to Infections”) and 13.9.1996, University of Turku
Doctorate, PhD 4.12.1997, University of Turku
Adjunct professor Internal Medicine/Clinical Haematology 18.4.2005, University of Turku

Professional appointments:

Resident/specialist in Internal Medicine and in Anaesthesia 1986-1997 Turku University Central Hospital.
Clinical haematologist, Turku University Central Hospital 1997-2007.
Medical Adviser, Janssen-Cilag, Nordic Section 2007-2008.  
Head of Department of Haematology, Tampere University Central Hospital 2008-2010.
Head of Stem Cell Transplant Unit, Turku University Hospital 2010-2017.
Head of Stem Cell Transplant Unit, Helsinki University Hospital 2017-2018.
Head of Division of Clinical Haematology and Stem Cell Transplant Unit, Programme Director of Stem Cell Transplant Unit, Turku University Central Hospital 2018-

Dissertations:

Supervisor 3, Opponent 2, Reviewer 4

Other academic appontments:

Review of the scientific work for docent application

Appointments in Scientific Societies:

Chair of the Finnish Society of Haematology 2012-2014, member 2014-.
Chair of the Finnish Acute Leukemia Working Group 2015-2018, member 2018-
The Nordic-Dutch Working Group for CLL (Chronic Lymphocytic Leukemia) Group, member 2000-2014.
The Finnish Haematology Registry and Biobank, member of the Steering group 2012-2014.
The European Group for Blood and Marrow Transplantation, member 1997-

Duties with National Authorities:

Consultant of the Parliament (Implementation of EU directives into National legislation) 2006-2007
Consultant of the Ministry of Social Affairs and Health (STM) 2016
Consultant of the Finnish Medicine Agency (Fimea) 2016-2018
EU consultation Brussels 2017

Activities in Quality Management:

Inspector exam of FACT/JACIE Quality Management System 31.5.2011, Rotterdam.
Establishment of the Quality Management System of the Stem Cell Unit of Turku University Hospital 2006; Moderation of initial JACIE accreditation and two re-accreditations 2006-2017 Turku University Central Hospital, Turku.


Teaching

Lectures at Finnish University Hospitals and Central Hospitals

Public lectures

Lectures at International meetings

Education of residents and junior colleagues (Clinical haematology and Stem Cell Transplantations)

Member of Faculty of the International Congress on Stem Cell Transplantation and Cellular Therapies, Berlin 2017

Research

Scientific publications and text book articles in field of stem cell transplantions and haematological malignancies

Principal Investigator and Sub-investigator of International Multicentre Clinical Trials

GCP training, latest update 22.2.2018

Publications

Sort by:

Increased MHC matching by C4 gene compatibility in URD HSCT (2019)

Biology of Blood and Marrow Transplantation
Jonna Clancy, Jarmo Ritari, Muriel Lobier, Riitta Niittyvuopio, Urpu Salmenniemi, Mervi Putkonen, Maija Itälä-Remes, Jukka Partanen, Satu Koskela
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL) (2019)

Bone Marrow Transplantation
Dreger P., Drozd-Sokolowska J., Eikema D., Wiktor-Jedrzejczak W., Wulf G., Sellner L., Hoek J., Potter M., Volin L., Koc Y., Ljungman P., Chevallier P., Rovira M., Itälä-Remes M., Martin S., Bunjes D., Cornelissen J., Gedde-Dahl T., Deconinck E., Foá R., de Groot M., Patel A., Brecht A., Collin M., Turlure P., Finke J., Nagler A., Reményi P., Kröger N., Schetelig J., van Biezen A., Iacobelli S.
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Comparative Outcomes of Myeloablative and Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Therapy-Related Acute Myeloid Leukemia with Prior Solid Tumor: a report from the ALWP of the EBMT (2019)

American Journal of Hematology
Lee CJ, Labopin M, Beelen D, Finke J, Blaise D, Ganser A, Itälä-Remes M, Chevallier P, Labussiére-Wallet H, Maertens J, Yakoub-Agha I, Bourhis JH, Mailhol A, Mohty M, Savani BN, Nagler A
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Gonadal Function after Busulfan Compared with Treosulfan in Children and Adolescents Undergoing Allogeneic Hematopoietic Stem Cell Transplant (2019)

Biology of Blood and Marrow Transplantation
Maura Faraci, Tamara Diesch, Myriam Labopin, Arnaud Dalissier, Arian Lankester, Andrew Gennery, Mikael Sundin, Duygu Uckan-Cetinkaya, Marc Bierings, Anke M.J. Peters, Martina Garwer, Ansgar Schulz, Gerard Michel, Giovanna Giorgiani, Bernd Gruhn, Franco Locatelli, Stefano Giardino, Anne Uyttebroeck, Fanny Rialland, Maija Itäla-Remes, Peter Dreger, Peter J. Shaw, Victoria Bordon, Paul G. Schlegel, Karin Mellgren, Jose M. Moraleda, Katharine Patrick, Pascale Schneider, Charlotte Jubert, Anita Lawitschka, Nina Salooja, Grzegorz W. Basak, Selim Corbaciuoglu, Rafael Duarte, Peter Bader
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

The Role of Anti-Thymocyte Globulin (ATG) in Patients with AML Transplanted in CR1 from Sibling and Unrelated Donors with or without Measurable Residual Disease (MRD) at the Time of Allogeneic Stem Cell Transplantation:a Study on Behalf of the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) (2019)

Biology of Blood and Marrow Transplantation
Arnon Nagler, Myriam Labopin, Gerard Socié, Anne Huynh, Maija Itälä-Remes, Eric Deconinck,Ibrahim Yakoub-Agha,
Jean-Yves Cahn, Jean Henri Bourhis, Hélène Labussière-Wallet,Sylvain Chantepie, Jordi Esteve, Mohamad Mohty
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Tandem Autologous Stem Cell Transplantation Improves Outcomes in Newly Diagnosed Multiple Myeloma with Extramedullary Disease and High-Risk Cytogenetics: A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation (2019)

Biology of Blood and Marrow Transplantation
Gagelmann N., Eikema D.-J., Koster L., Caillot D., Pioltelli P., Lleonart J.B., Reményi P., Blaise D., Schaap N., Trneny M., Passweg J., Porras R.P., Cahn J.Y., Musso M., Poiré X., Fenk R., Itälä-Remes M., Pavone V., Fouillard L., Maertens J., Bron D., Pouli A., Schroyens W., Schönland S., Garderet L., Yakoub-Agha I., Kröger N.
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))
People search